AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 31229695 — intervention group
Group type: EXPERIMENTAL
Intervention: Comparison of precurriculum confidence between genders
Number of subjects: 49
Study 31229695 — intervention group
Group type: EXPERIMENTAL
Intervention: Postcurriculum confidence between genders
Number of subjects: 49
Study 31229695 — intervention group
Group type: EXPERIMENTAL
Intervention: Correlation between self-reported confidence and prior experience
Number of subjects: 49
Study 31229695 — intervention group
Group type: EXPERIMENTAL
Intervention: Correlation between self-reported confidence and performance
Number of subjects: 49
Study 27187047 — intervention group
Group type: EXPERIMENTAL
Intervention: Closure of visceral and parietal peritoneums (group 2)
Number of subjects: 133
Study 27187047 — intervention group
Group type: COMPARATOR
Intervention: Closure of parietal peritoneum only (group 1)
Number of subjects: 133
Study 27187047 — intervention group
Group type: COMPARATOR
Intervention: No closure of peritoneums (group 3)
Number of subjects: 133
Study 27187047 — intervention group
Group type: COMPARATOR
Intervention: Closure of visceral peritoneum only (group 4)
Number of subjects: 133
Study 25589559 — intervention group
Group type: EXPERIMENTAL
Intervention: Saline flushing every 12 hours (group A)
Number of subjects: 400
Study 25589559 — intervention group
Group type: COMPARATOR
Intervention: Saline flushing every 24 hours (group B)
Number of subjects: 400
Study 23861288 — intervention group
Group type: EXPERIMENTAL
Intervention: Cluster 1 (high optimism, low negative affect, pain vigilance, anger, and depression)
Number of subjects: 194
Study 23861288 — intervention group
Group type: EXPERIMENTAL
Intervention: Cluster 2 (low positive affect, high somatic reactivity)
Number of subjects: 194
Study 23861288 — intervention group
Group type: EXPERIMENTAL
Intervention: Cluster 3 (high pain vigilance, low optimism)
Number of subjects: 194
Study 23861288 — intervention group
Group type: EXPERIMENTAL
Intervention: Cluster 4 (highest pain vigilance, reactivity, negative affect, anger, and depression)
Number of subjects: 194
Study 21242173 — intervention group
Group type: EXPERIMENTAL
Intervention: Targeted recruitment strategies at seven institutions
Number of subjects: 18442
Study 21242173 — intervention group
Group type: COMPARATOR
Intervention: Non-targeted recruitment at institutions without strategies
Number of subjects: 18442
Study 21242173 — intervention group
Group type: EXPERIMENTAL
Intervention: Cost of targeted recruitment strategies
Number of subjects: 18442
Study 19583677 — intervention group
Group type: EXPERIMENTAL
Intervention: Omeprazole 40 mg (oral dose)
Number of subjects: 150
Study 17033927 — intervention group
Group type: EXPERIMENTAL
Intervention: Exemestane therapy
Number of subjects: 0
Study 17033927 — intervention group
Group type: COMPARATOR
Intervention: Tamoxifen therapy
Number of subjects: 0
Study 15534410 — intervention group
Group type: EXPERIMENTAL
Intervention: OP‐1 Putty (3.5 mg of OP‐1 per side)
Number of subjects: 36
Study 15534410 — intervention group
Group type: COMPARATOR
Intervention: Autogenous iliac crest bone graft
Number of subjects: 36
Study 15534410 — intervention group
Group type: EXPERIMENTAL
Intervention: Both OP‐1 Putty and autograft
Number of subjects: 36
Study 15534410 — intervention group
Group type: EXPERIMENTAL
Intervention: OP‐1 Putty
Number of subjects: 36
Study 11535566 — intervention group
Group type: EXPERIMENTAL
Intervention: Folic acid (10 mg once a day)
Number of subjects: 18
Study 11535566 — intervention group
Group type: EXPERIMENTAL
Intervention: Folic acid plus transdermal GTN
Number of subjects: 18
Study 11535566 — intervention group
Group type: COMPARATOR
Intervention: Transdermal GTN plus placebo
Number of subjects: 18
Study 9918450 — intervention group
Group type: EXPERIMENTAL
Intervention: Active Compression-Decompression (ACD) CPR
Number of subjects: 60
Study 9918450 — intervention group
Group type: COMPARATOR
Intervention: Standard CPR
Number of subjects: 60
Study 9918450 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients admitted to hospital
Number of subjects: 60
Study 9918450 — intervention group
Group type: COMPARATOR
Intervention: Patients declared dead at the scene
Number of subjects: 60
Study 7845167 — intervention group
Group type: EXPERIMENTAL
Intervention: Omeprazole 3x40 mg + Amoxicillin 3x750 mg for 14 days
Number of subjects: 0
Study 7845167 — intervention group
Group type: COMPARATOR
Intervention: Classical triple therapy containing bismuth and two antibiotics
Number of subjects: 0
Study 2904006 — intervention group
Group type: EXPERIMENTAL
Intervention: 100 micrograms misoprostol
Number of subjects: 420
Study 2904006 — intervention group
Group type: EXPERIMENTAL
Intervention: 200 micrograms misoprostol
Number of subjects: 420
Study 2904006 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 420
Study 31210361 — intervention group
Group type: EXPERIMENTAL
Intervention: Growth mindset peer context
Number of subjects: 134
Study 31210361 — intervention group
Group type: COMPARATOR
Intervention: Fixed mindset peer context
Number of subjects: 134
Study 28508396 — intervention group
Group type: EXPERIMENTAL
Intervention: Partner child intentionally defected
Number of subjects: 144
Study 28508396 — intervention group
Group type: EXPERIMENTAL
Intervention: Partner child was ignorant about how to play
Number of subjects: 144
Study 28508396 — intervention group
Group type: EXPERIMENTAL
Intervention: Apparatus broke
Number of subjects: 144
Study 28950837 — intervention group
Group type: EXPERIMENTAL
Intervention: Active commuting to/from school
Number of subjects: 300
Study 28950837 — intervention group
Group type: EXPERIMENTAL
Intervention: Active Physical Education lessons
Number of subjects: 300
Study 28950837 — intervention group
Group type: EXPERIMENTAL
Intervention: Active school recess
Number of subjects: 300
Study 28950837 — intervention group
Group type: EXPERIMENTAL
Intervention: Sleep health promotion
Number of subjects: 300
Study 28950837 — intervention group
Group type: EXPERIMENTAL
Intervention: Integrated program incorporating all 4 interventions
Number of subjects: 300
Study 28950837 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 300
Study 25708419 — intervention group
Group type: EXPERIMENTAL
Intervention: Probiotic preparation administered twice a day from ICU admission until 7 days or discharge from ICU.
Number of subjects: 150
Study 25708419 — intervention group
Group type: COMPARATOR
Intervention: Control group (no probiotics administered).
Number of subjects: 150
Study 23076723 — intervention group
Group type: EXPERIMENTAL
Intervention: rTMS-COG
Number of subjects: 15
Study 23076723 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15
Study 20644484 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.8 g MnCl2 (n = 11)
Number of subjects: 20
Study 20644484 — intervention group
Group type: EXPERIMENTAL
Intervention: 1.6 g MnCl2 (n = 9)
Number of subjects: 20
Study 20644484 — intervention group
Group type: EXPERIMENTAL
Intervention: Both doses (0.8 g and 1.6 g MnCl2)
Number of subjects: 20
Study 18300337 — intervention group
Group type: EXPERIMENTAL
Intervention: 10-month program of tailored mailed print materials
Number of subjects: 543
Study 18300337 — intervention group
Group type: COMPARATOR
Intervention: 10-month program of publicly available materials on diet and exercise
Number of subjects: 543
Study 16628671 — intervention group
Group type: EXPERIMENTAL
Intervention: peginterferon α-2a plus ribavirin
Number of subjects: 216
Study 12905094 — intervention group
Group type: EXPERIMENTAL
Intervention: Laboratory treadmill running test
Number of subjects: 10
Study 12905094 — intervention group
Group type: COMPARATOR
Intervention: Field roller skiing test
Number of subjects: 10
Study 10843351 — intervention group
Group type: EXPERIMENTAL
Intervention: 12-week group exercise program (90 minutes, three times per week)
Number of subjects: 59
Study 10843351 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 59
Study 9158845 — intervention group
Group type: EXPERIMENTAL
Intervention: Taste information
Number of subjects: 0
Study 9158845 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin-plus-availability information
Number of subjects: 0
Study 9158845 — intervention group
Group type: COMPARATOR
Intervention: No information
Number of subjects: 0
Study 7942443 — intervention group
Group type: EXPERIMENTAL
Intervention: Bedside coagulation device
Number of subjects: 120
Study 7942443 — intervention group
Group type: COMPARATOR
Intervention: Central laboratory aPTT testing
Number of subjects: 120
Study 3067116 — intervention group
Group type: EXPERIMENTAL
Intervention: Tianeptine (37.5 mg per day)
Number of subjects: 129
Study 3067116 — intervention group
Group type: COMPARATOR
Intervention: Amitriptyline (75 mg per day)
Number of subjects: 129
Study 29691148 — intervention group
Group type: EXPERIMENTAL
Intervention: Angiotensin receptor blocker (ARB) - valsartan
Number of subjects: 30
Study 29691148 — intervention group
Group type: EXPERIMENTAL
Intervention: ACE inhibitor (ACEI) - ramipril
Number of subjects: 30
Study 29691148 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study 28533054 — intervention group
Group type: EXPERIMENTAL
Intervention: 4CMenB vaccine (2+1 doses at 3½-5-11 months or 6-8-11 months)
Number of subjects: 1158
Study 28533054 — intervention group
Group type: EXPERIMENTAL
Intervention: 4CMenB vaccine (3+1 doses at ages 2½-3½-5-11 months)
Number of subjects: 1158
Study 28533054 — intervention group
Group type: EXPERIMENTAL
Intervention: 4CMenB vaccine (2 catch-up doses administered 2 months apart)
Number of subjects: 1158
Study 28533054 — intervention group
Group type: EXPERIMENTAL
Intervention: Adverse events monitoring
Number of subjects: 1158
Study 26386693 — intervention group
Group type: EXPERIMENTAL
Intervention: Meal rich in saturated fat (butter) with 1.8 grams of LCn‐3PUFA
Number of subjects: 26
Study 26386693 — intervention group
Group type: EXPERIMENTAL
Intervention: Meal rich in omega-6 polyunsaturated fatty acids (sunflower seed oil) with 1.8 grams of LCn‐3PUFA
Number of subjects: 26
Study 26386693 — intervention group
Group type: COMPARATOR
Intervention: Both saturated fat and omega-6 fat groups with 1.8 grams of LCn‐3PUFA
Number of subjects: 26
Study 23846749 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydromorphone titration protocol (0.5 mg intravenous hydromorphone initially, with a second dose of 0.5 mg if requested)
Number of subjects: 319
Study 23846749 — intervention group
Group type: COMPARATOR
Intervention: Usual care (any dose of any intravenous opioid)
Number of subjects: 319
Study 21952034 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 mg vitamin B12 pill taken daily and routine PACAM food
Number of subjects: 300
Study 21952034 — intervention group
Group type: EXPERIMENTAL
Intervention: Placebo pill and milk-PACAM food fortified to provide 1 mg of vitamin B12
Number of subjects: 300
Study 21952034 — intervention group
Group type: COMPARATOR
Intervention: Routine PACAM food and placebo pill
Number of subjects: 300
Study 18978634 — intervention group
Group type: EXPERIMENTAL
Intervention: Antidepressant medication management plus relapse prevention cognitive-behavioral therapy (MM+CBT)
Number of subjects: 46
Study 18978634 — intervention group
Group type: COMPARATOR
Intervention: Antidepressant medication management (MM)
Number of subjects: 46
Study 17013852 — intervention group
Group type: EXPERIMENTAL
Intervention: 6-week exercise intervention
Number of subjects: 108
Study 17013852 — intervention group
Group type: COMPARATOR
Intervention: Education (control)
Number of subjects: 108
Study 12729423 — intervention group
Group type: EXPERIMENTAL
Intervention: 10-day oral doxycycline
Number of subjects: 180
Study 12729423 — intervention group
Group type: EXPERIMENTAL
Intervention: 20-day oral doxycycline
Number of subjects: 180
Study 12729423 — intervention group
Group type: EXPERIMENTAL
Intervention: Doxycycline + ceftriaxone (single intravenous dose)
Number of subjects: 180
Study 12729423 — intervention group
Group type: COMPARATOR
Intervention: Control group without Lyme disease
Number of subjects: 180
Study 10934099 — intervention group
Group type: EXPERIMENTAL
Intervention: Inhaled PGE(2) (100 microgram)
Number of subjects: 10
Study 10934099 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study 8959182 — intervention group
Group type: EXPERIMENTAL
Intervention: Ionic contrast material (ioxaglate)
Number of subjects: 98
Study 8959182 — intervention group
Group type: COMPARATOR
Intervention: Nonionic contrast material (iopamidol or iohexol)
Number of subjects: 98
Study 1525104 — intervention group
Group type: EXPERIMENTAL
Intervention: gemeprost alone (1 mg every 6 h up to three doses)
Number of subjects: 301
Study 1525104 — intervention group
Group type: COMPARATOR
Intervention: mifepristone (200‐600 mg) followed 48 h later by a single dose of gemeprost (1 mg)
Number of subjects: 301
Study 1525104 — intervention group
Group type: COMPARATOR
Intervention: mifepristone and gemeprost
Number of subjects: 301
Study 3761089 — intervention group
Group type: EXPERIMENTAL
Intervention: Mother's own milk (HM) with protein intake 3.3 gm/kg day
Number of subjects: 38
Study 3761089 — intervention group
Group type: EXPERIMENTAL
Intervention: Fortified mother's own milk (fortified HM) with protein intake 4.5 gm/kg/day
Number of subjects: 38
Study 3761089 — intervention group
Group type: EXPERIMENTAL
Intervention: Similac Special Care (Similac SC) with protein intake 2.9 gm/kg/day
Number of subjects: 38
Study 3761089 — intervention group
Group type: EXPERIMENTAL
Intervention: Similac with protein intake 2.7 gm/kg/day
Number of subjects: 38
Study 28982101 — intervention group
Group type: EXPERIMENTAL
Intervention: Misoprostol (2 tablets, 400 µg administered vaginally 12 hours before hysteroscopy)
Number of subjects: 100
Study 28982101 — intervention group
Group type: COMPARATOR
Intervention: Placebo (2 placebo tablets administered)
Number of subjects: 100
Study 27176138 — intervention group
Group type: EXPERIMENTAL
Intervention: Rolapitant (180 mg)
Number of subjects: 401
Study 27176138 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 401
Study 24112749 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-measurement of INR using a personal device
Number of subjects: 178
Study 24112749 — intervention group
Group type: COMPARATOR
Intervention: Laboratory-analyzed INR monitoring
Number of subjects: 178
Study 22351940 — intervention group
Group type: EXPERIMENTAL
Intervention: ASP2151 (100 mg daily for 3 days)
Number of subjects: 437
Study 22351940 — intervention group
Group type: EXPERIMENTAL
Intervention: ASP2151 (200 mg daily for 3 days)
Number of subjects: 437
Study 22351940 — intervention group
Group type: EXPERIMENTAL
Intervention: ASP2151 (400 mg daily for 3 days)
Number of subjects: 437
Study 22351940 — intervention group
Group type: EXPERIMENTAL
Intervention: ASP2151 (1200 mg as a single dose)
Number of subjects: 437
Study 22351940 — intervention group
Group type: EXPERIMENTAL
Intervention: Valacyclovir (500 mg twice daily for 3 days)
Number of subjects: 437
Study 22351940 — intervention group
Group type: COMPARATOR
Intervention: Placebo for 3 days
Number of subjects: 437
Study 21211387 — intervention group
Group type: EXPERIMENTAL
Intervention: Laryngeal mask airway (LMA) under deep anesthesia (group LM)
Number of subjects: 40
Study 21211387 — intervention group
Group type: COMPARATOR
Intervention: Intratracheal tube extubation when awake (group TT)
Number of subjects: 40
Study 18692661 — intervention group
Group type: EXPERIMENTAL
Intervention: Right gastroepiploic artery graft
Number of subjects: 370
Study 18692661 — intervention group
Group type: COMPARATOR
Intervention: Saphenous vein graft
Number of subjects: 370
Study 15907554 — intervention group
Group type: EXPERIMENTAL
Intervention: Caspofungin (50 mg/day after a 70 mg loading dose)
Number of subjects: 224
Study 15907554 — intervention group
Group type: COMPARATOR
Intervention: Amphotericin B (0.6-1.0 mg/kg/day)
Number of subjects: 224
Study 15907554 — intervention group
Group type: EXPERIMENTAL
Intervention: Caspofungin
Number of subjects: 224
Study 15907554 — intervention group
Group type: COMPARATOR
Intervention: Amphotericin B
Number of subjects: 224
Study 14753637 — intervention group
Group type: EXPERIMENTAL
Intervention: Midazolam (mean 12.5 mg)
Number of subjects: 141
Study 14753637 — intervention group
Group type: COMPARATOR
Intervention: Diazepam (mean 28.1 mg)
Number of subjects: 141
Study 10496496 — intervention group
Group type: EXPERIMENTAL
Intervention: NISWT
Number of subjects: 24
Study 8541435 — intervention group
Group type: EXPERIMENTAL
Intervention: Balanced anaesthesia technique with isoflurane and fentanyl
Number of subjects: 15
Study 8541435 — intervention group
Group type: COMPARATOR
Intervention: Total intravenous anaesthesia with propofol and alfentanil
Number of subjects: 15
Study 1752112 — intervention group
Group type: EXPERIMENTAL
Intervention: Pefloxacin alone (period A)
Number of subjects: 8
Study 1752112 — intervention group
Group type: COMPARATOR
Intervention: Pefloxacin after a 10-day induction by rifampin (period B)
Number of subjects: 8
Study 7457638 — intervention group
Group type: EXPERIMENTAL
Intervention: 3 mg/kg of caffeine
Number of subjects: 19
Study 7457638 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 mg/kg of caffeine
Number of subjects: 19
Study 7457638 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 19
Study 31200757 — intervention group
Group type: EXPERIMENTAL
Intervention: Bridge intervention to identify, test, and link HIV-positive PWID to HIV care
Number of subjects: 24
Study 31200757 — intervention group
Group type: COMPARATOR
Intervention: Not applicable
Number of subjects: 24
Study 27787672 — intervention group
Group type: EXPERIMENTAL
Intervention: Reinforcement
Number of subjects: 29
Study 27787672 — intervention group
Group type: EXPERIMENTAL
Intervention: Methylphenidate (0.3 and 0.6 mg/kg)
Number of subjects: 29
Study 25906785 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous glucose monitoring (CGM)
Number of subjects: 117
Study 25906785 — intervention group
Group type: EXPERIMENTAL
Intervention: Trimester 1 mean glucose
Number of subjects: 117
Study 25906785 — intervention group
Group type: EXPERIMENTAL
Intervention: Trimester 2 mean glucose
Number of subjects: 117
Study 25906785 — intervention group
Group type: EXPERIMENTAL
Intervention: Trimester 3 mean glucose
Number of subjects: 117
Study 25906785 — intervention group
Group type: EXPERIMENTAL
Intervention: Glucose levels at specific times of day
Number of subjects: 117
Study 24412457 — intervention group
Group type: EXPERIMENTAL
Intervention: Drug-eluting balloon (DEB)
Number of subjects: 189
Study 24412457 — intervention group
Group type: COMPARATOR
Intervention: Everolimus-eluting stent (EES)
Number of subjects: 189
Study 24412457 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined clinical outcome measure (cardiac death, myocardial infarction, target vessel revascularization)
Number of subjects: 189
Study 24412457 — intervention group
Group type: EXPERIMENTAL
Intervention: Target vessel revascularization
Number of subjects: 189
Study 22982353 — intervention group
Group type: EXPERIMENTAL
Intervention: Contraceptive vaginal ring (CVR) delivering 150/15 μg Nestorone®/ethinyl estradiol (EE) daily
Number of subjects: 45
Study 22982353 — intervention group
Group type: COMPARATOR
Intervention: Oral contraceptive (OC) containing levonorgestrel and EE (150/30 μg)
Number of subjects: 45
Study 19383221 — intervention group
Group type: EXPERIMENTAL
Intervention: Valsartan/hydrochlorothiazide 80 mg/12.5 mg once daily
Number of subjects: 65
Study 19383221 — intervention group
Group type: COMPARATOR
Intervention: Amlodipine 5 mg once daily
Number of subjects: 65
Study 17461960 — intervention group
Group type: EXPERIMENTAL
Intervention: Hyaluronic Acid (HA)
Number of subjects: 30
Study 17461960 — intervention group
Group type: COMPARATOR
Intervention: Chlorhexidine (CHX)
Number of subjects: 30
Study 15113295 — intervention group
Group type: EXPERIMENTAL
Intervention: Cotton wool with petroleum jelly
Number of subjects: 10
Study 15113295 — intervention group
Group type: COMPARATOR
Intervention: Other earplugs
Number of subjects: 10
Study 12270068 — intervention group
Group type: EXPERIMENTAL
Intervention: Erythropoietin (EPO)
Number of subjects: 19
Study 12270068 — intervention group
Group type: COMPARATOR
Intervention: No therapy or placebo
Number of subjects: 19
Study 9717596 — intervention group
Group type: EXPERIMENTAL
Intervention: 4 ml lidocaine 1%
Number of subjects: 48
Study 9717596 — intervention group
Group type: EXPERIMENTAL
Intervention: 6 ml lidocaine 1%
Number of subjects: 48
Study 9717596 — intervention group
Group type: EXPERIMENTAL
Intervention: 8 ml lidocaine 1%
Number of subjects: 48
Study 8122656 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketoconazole 200 mg/day p.o.
Number of subjects: 122
Study 8122656 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluconazole 50 mg/day p.o.
Number of subjects: 122
Study 8122656 — intervention group
Group type: COMPARATOR
Intervention: No antifungal therapy
Number of subjects: 122
Study 2549204 — intervention group
Group type: EXPERIMENTAL
Intervention: 500 mg/m2 as a continuous intravenous (IV) infusion over 24 hours
Number of subjects: 39
Study 2549204 — intervention group
Group type: EXPERIMENTAL
Intervention: Five consecutive daily 2-hour infusions each of 100 mg/m2
Number of subjects: 39
Study 16815 — intervention group
Group type: EXPERIMENTAL
Intervention: Lorazepam
Number of subjects: 0
Study 16815 — intervention group
Group type: COMPARATOR
Intervention: Diazepam
Number of subjects: 0
Study 16815 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 31422486 — intervention group
Group type: EXPERIMENTAL
Intervention: Fast Food (FF) diet
Number of subjects: 10
Study 31422486 — intervention group
Group type: EXPERIMENTAL
Intervention: Mediterranean (Med) diet
Number of subjects: 10
Study 31422486 — intervention group
Group type: COMPARATOR
Intervention: Control (not specified)
Number of subjects: 10
Study 28870034 — intervention group
Group type: EXPERIMENTAL
Intervention: Insulin degludec (IDeg)
Number of subjects: 560
Study 28870034 — intervention group
Group type: COMPARATOR
Intervention: Insulin glargine (IGlar)
Number of subjects: 560
Study 26160368 — intervention group
Group type: EXPERIMENTAL
Intervention: Telemonitoring intervention (Tele-HF trial)
Number of subjects: 1427
Study 23204058 — intervention group
Group type: EXPERIMENTAL
Intervention: Early tracheostomy (within day 1-3 from intubation)
Number of subjects: 60
Study 23204058 — intervention group
Group type: COMPARATOR
Intervention: Standard tracheostomy (between day 7-14 from intubation)
Number of subjects: 60
Study 21865202 — intervention group
Group type: EXPERIMENTAL
Intervention: Antioxidant vitamins (C and E)
Number of subjects: 567
Study 18926516 — intervention group
Group type: EXPERIMENTAL
Intervention: Drain placed (group A)
Number of subjects: 284
Study 18926516 — intervention group
Group type: COMPARATOR
Intervention: No drain placed (group B)
Number of subjects: 284
Study 16960528 — intervention group
Group type: EXPERIMENTAL
Intervention: Esophageal acid perfusion (0.1 N HCl perfused)
Number of subjects: 24
Study 16960528 — intervention group
Group type: EXPERIMENTAL
Intervention: Acid perfusion during exercise
Number of subjects: 24